Td2 401(K) Plan — Form 5500 plan (Translational Drug Development, LLC)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Td2 401(K) Plan is a benefit plan reported by Translational Drug Development, LLC under EIN 46-4150915 and plan number 001. The latest loaded filing year is 2023. The filing reports 208 participants and $10,281,224 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Translational Drug Development, LLC
- EIN
- 46-4150915
- Plan number
- 001
- Plan type
- 2
- Location
- Scottsdale, AZ
- Latest filing year
- 2023
How to read this plan profile
- Net assets = total assets minus total liabilities, end of year (Schedule H/I).
- Assets / participant is computed (assets ÷ reported participants) — a ratio, not a filed figure.
- Schedule chips (Sch H / I / C) show which schedules each filing includes.
- Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
- Figures are reported as filed, in whole dollars; verify against the official DOL/EBSA record before relying on them.
Form 5500 filing history
Each loaded annual filing for this plan. Open one for its full reported snapshot.
- 2023Sch HSch CView filing →
Reported financial statement
Reported figures as filed, in whole dollars. Only fields the filing reports are shown; others are marked not reported.
Full reported line items
Net assets
- Total assets (EOY)
- $10,281,224
- Net assets (EOY)
- $10,281,224
- Net assets (BOY)
- $8,104,055
Income & contributions
- Employer contributions
- $999,872
- Participant contributions
- $1,391,414
- Total contributions
- $2,487,697
- Total income / additions
- $4,001,153
Expenses & distributions
- Benefits paid
- $1,758,332
- Administrative expenses
- $65,652
- Total expenses
- $1,823,984
- Net increase / (decrease)
- $2,177,169
Reported ratios
Derived only from this plan's own reported figures — comparisons within the filing, not benchmarks, estimates, or national averages.
Service provider compensation
Reported direct + indirect compensation per provider, ranked. Bars show relative scale.
- 1
- 2
Frequently asked questions
- Who sponsors the Td2 401(K) Plan?
- Td2 401(K) Plan is reported as sponsored by Translational Drug Development, LLC (EIN 46-4150915, plan number 001) in public Form 5500 filings.
- What is the most recent Form 5500 filing year for Td2 401(K) Plan?
- The latest Form 5500 filing year loaded for Td2 401(K) Plan is 2023.
- How many participants does Td2 401(K) Plan report?
- Td2 401(K) Plan reports 208 participants in its latest loaded Form 5500 filing.
- What are the reported plan assets for Td2 401(K) Plan?
- Td2 401(K) Plan reports $10,281,224 in end-of-year plan assets in its latest loaded Form 5500 filing.
Form 5500 terms, in plain English
- Form 5500
- The annual report most U.S. employee benefit plans file with the Department of Labor through the EFAST2 system. It documents the plan sponsor, participants, finances, and service-provider compensation.
- Schedule H
- The financial statement for larger plans (generally 100+ participants): assets, liabilities, net assets, income, expenses, and the net change.
- Schedule I
- The condensed financial statement for smaller plans, covering the same kinds of figures in less detail.
- Schedule C
- Reports compensation paid to the plan’s service providers — both direct and indirect.
- Net assets
- Total assets minus total liabilities at the end of the year — what the plan holds for participants.
- Employer / participant contributions
- Money contributed to the plan by the employer and by participants during the year.
Figures are reported as filed and may contain errors or omissions. Verify against the official DOL/EBSA record before relying on any value.